Drug persistence of omalizumab, cyclosporine,and hydroxychloroquinein antihistamine-refractory chronic spontaneous urticaria: A biomarker-stratified real-world study
Real-world comparative data on alternatives to omalizumab for antihistamine-refractory chronic spontaneous urticaria (CSU) are limited, particularly in resource-constrained Asia-Pacific settings.